martes, 28 de abril de 2026

Rewriting the Genetic Code: Designing Biologics with Noncanonical Amino Acids avatar David Alvaro, Ph.D. Editor in Chief April Stanley, MS MBA Senior Scientific Research Director and M&A Advisor Nice Insight

Rewriting the Genetic Code: Designing Biologics with Noncanonical Amino Acids David Alvaro, Ph.D. Editor in Chief April Stanley, MS MBA Senior Scientific Research Director and M&A Advisor Nice Insight https://www.pharmasalmanac.com/articles/rewriting-the-genetic-code-designing-biologics-with-noncanonical-amino-acids Advances in genetic code expansion are enabling the incorporation of noncanonical amino acids into proteins, expanding the chemical capabilities of biologics and opening new possibilities for designing therapeutic proteins with precisely engineered functions.

No hay comentarios:

Publicar un comentario